Is specialist cartilage repair right for my knee pain

Cartilage repair tends to come into the conversation when the knee has a local problem rather than a globally “worn out” joint: a contained cartilage “pothole” that is driving symptoms, versus widespread osteoarthritis where most of the joint surface is thinning like a road that has worn away end-to-end. This overview is a general decision framework, not a service advert, because the same clinical logic applies regardless of provider.

A practical way to place cartilage repair is as the third step in a four-part pathway: (1) symptom management (rehabilitation, load management and pain relief), (2) injection/biologic support in selected cases, (3) cartilage restoration/scaffold repair for suitable focal defects, and (4) knee replacement when arthritis is diffuse and structural.

For a typical focal-defect scenario—such as knee pain after a twist injury where imaging suggests a single, well-defined defect—minimally invasive, image-guided options may be discussed before committing to bigger reconstructive surgery. In some private-clinic pathways, injectable collagen-scaffold products (for example, “Liquid Cartilage”/ChondroFiller-type products) may be offered for selected focal defects; product-specific regulatory status, mechanism descriptions and package components vary by jurisdiction/provider and should be checked in primary manufacturer/regulatory materials.

If the defect is larger, needs mechanical stimulation of the bone beneath, or requires a procedure with longer follow-up evidence, surgery is more likely to be considered. AMIC is generally described as a one-stage approach that augments microfracture with a collagen membrane, while MACI is described as a cell-based technique supported by randomised trials and long-term cohorts. [1]

Evidence strength is part of the choice: MACI has published outcomes beyond 10 years in long-term cohorts, while many single-stage approaches (including newer one-step concepts) tend to have shorter-term and more heterogeneous evidence to date. [1]

Where the knee is globally arthritic rather than focal, cartilage repair is less likely to match the problem, and joint-preserving options shift towards alignment strategies or, ultimately, arthroplasty rather than defect filling.

How MRI and ultrasound map your knee cartilage damage

Imaging is usually what turns a general label like “knee cartilage wear” into a precise map of where the problem sits and whether it is focal and treatable, or part of broader osteoarthritis that is more likely to be managed with load-modifying strategies or (in later stages) arthroplasty.

In clinic pathways, the starting point is typically a consultation (history and examination) followed by imaging to match symptoms to structure. Weight-bearing X‑rays are commonly used to look indirectly for cartilage loss via joint-space narrowing, and to check alignment across the knee compartments; CT tends to be reserved for selected pre-operative planning rather than routine cartilage assessment. MRI then becomes the main test used to visualise cartilage directly, alongside the meniscus, ligaments and the bone under the cartilage (subchondral bone). This sequence—clinical assessment → X‑ray where appropriate → MRI when cartilage detail matters—helps decide whether a focal repair pathway is realistic.

MRI works using strong magnetic fields and radio waves (no ionising radiation) to produce cross-sectional images of the knee. In practical terms, it is relied upon because it can show the size, depth and location of a cartilage defect and whether there are associated features—such as bone marrow change—relevant to planning a cartilage procedure. In some cases, extra cartilage-focused MRI analysis is added (for example, cartilage mapping sequences in selected protocols) to give more information about cartilage quality.

Diagnostic ultrasound plays a different role. It is strong for superficial and “front-of-knee” structures, joint effusion, synovitis and dynamic assessment in real time, but it is less suited than MRI to grading deep central cartilage surfaces across the femoral condyles. This is why ultrasound commonly complements MRI rather than replacing it when planning cartilage restoration.

Even with good imaging, uncertainty can remain. A retrospective comparison of MRI reports versus arthroscopy in 190 knees found that standard 1.5T MRI often underestimated cartilage lesion grade and extent, with very low sensitivity (around 5%) for low-grade (grade I) lesions, and lower accuracy laterally than medially. This is one reason some patients still go on to arthroscopy for confirmation and/or treatment when symptoms, examination and MRI are not aligned. [2]

When an ultrasound-guided Liquid Cartilage injection is considered

Three things tend to need to line up before an ultrasound-guided Liquid Cartilage™ (ChondroFiller™) injection is put on the table for a knee: (1) a clearly defined focal cartilage defect, (2) a knee that is otherwise mechanically “workable”, and (3) symptoms that match the imaging and examination findings. In other words, it is generally discussed for a contained “pothole” lesion rather than a knee that is globally arthritic across multiple compartments.

Liquid Cartilage™ is often described in provider/manufacturer materials as an injectable collagen scaffold placed directly into a mapped defect, with the aim of supporting defect filling over time. (Patients should rely on their treating clinician and primary manufacturer/regulatory information for definitive product claims.)

In clinic pathways, the “map” for injection decisions is typically built from clinical assessment plus imaging, with MRI used to define the defect and to check related structures such as the meniscus, ligaments and subchondral bone. Where ultrasound guidance is used procedurally, the intent is to support real-time needle placement rather than a landmark (unguided) approach.

A practical screening checklist used in many cartilage-restoration decisions is whether the knee has factors that can overload a localised repair. Examples commonly weighed up include advanced, widespread osteoarthritis, major malalignment (where an offloading osteotomy may be the more logical joint-preservation step), ligament instability, and significant meniscal deficiency—because these can shift contact pressures onto the defect area even if an injectable material is accurately placed.

The realistic aim is symptom improvement—typically described as pain reduction and functional gain—rather than promising guaranteed “regrowth” of normal cartilage. In broader knee cartilage-restoration overviews, established surgical options such as MACI are supported by longer-term cohort evidence (including outcomes beyond 10 years), whereas many lower-burden single-stage approaches have comparatively less mature long-term data. [1]

How single treatment ACI differs from two stage ACI and MACI

The main difference between classic ACI/MACI and single-treatment ACI (STACI) is the number of procedures built into the journey: two planned operations versus an attempt to achieve a chondrocyte-based repair in one sitting.

Two-stage ACI: assessment/biopsy first, implantation later

In classic knee ACI, the first step is typically an arthroscopy used to assess the joint and take a cartilage biopsy for laboratory expansion. The second step is a later operation where the cultured cells are implanted into the prepared defect. This staged approach is one reason ACI has often been positioned for symptomatic, focal defects where the anticipated benefit justifies two anaesthetics and a longer logistical pathway. [3]

Two-stage MACI: a membrane-based evolution, not a one-stage procedure

MACI is described as a cell-based approach supported by randomised trials and long-term cohorts, and is typically performed as a staged pathway involving harvest/assessment followed by later implantation after cell expansion and graft preparation. [1]

Why the two-stage pathway can feel “high commitment”

Because ACI/MACI is planned as a staged programme, it can mean two admissions, two anaesthetics, and two phases of post-operative restriction and rehabilitation, alongside the practicalities of time off work and travel. [3]

STACI: the single-operation ambition, with an earlier evidence base

Broader overviews describe a range of single-stage cartilage restoration strategies intended to reduce procedural burden and avoid laboratory cell expansion, with generally favourable short- to mid-term outcomes in selected small-to-moderate lesions—while emphasising that long-term, high-quality comparative evidence can be more limited than for established MACI cohorts. [1]

Adjacent one-stage biologic papers also illustrate the evidence challenge: a technical description of a single-stage bone marrow–derived mesenchymal stem cell transplantation approach for knee osteochondral defects reported improvement in a three-patient series at short follow-up and highlighted the need for larger prospective and randomised trials when comparing against established ACI/MACI. [3]

MACI or AMIC for medium sized knee cartilage defects

Medium-sized focal knee cartilage defects are often the ones that create the most uncertainty: big enough that a simple marrow-stimulation approach may be less attractive, but not so large that a major graft-based strategy is the obvious next step. In practice, clinicians often use “medium-sized” to mean a contained lesion on a femoral condyle or a patellofemoral surface that is large enough to matter biomechanically, yet still potentially suitable for joint-preserving restoration rather than arthroplasty.

MACI: higher-commitment pathway, stronger long-term track record

MACI sits at the more established end of cartilage restoration for the knee: it is described as supported by randomised trials and long-term cohort data, with outcomes reported beyond 10 years, particularly in younger, active patients with a more isolated defect pattern. [1]

AMIC: one operation that augments microfracture with a membrane

AMIC is described as a single-stage approach that augments microfracture with membrane coverage, intended to stabilise the marrow clot and support repair. [1]

What comparative evidence suggests (and what it still cannot answer)

Comparative summaries cited in broader treatment overviews suggest that both MACI and AMIC can deliver substantial improvements in pain and function for focal chondral knee defects, while also highlighting that the depth of long-term evidence is generally greater for MACI and that high-quality head-to-head data guiding MACI vs AMIC choice remain limited. [1]

Decision drivers that often push the choice one way or the other

• When “durability evidence” is the priority (for example, a larger isolated defect in a younger, active knee with otherwise manageable mechanics), MACI is frequently weighted more strongly because sustained improvements have been reported beyond 10 years in long-term cohorts.
• When “one procedure, lower resource burden” is the priority, AMIC is often considered because it is typically positioned as a single-stage option, acknowledging the trade-off of less robust long-duration comparison data versus MACI.

Across both techniques, the same surface-restoration overview stresses that outcomes depend heavily on patient selection and meticulous technique, and that studies often pool different lesion locations and sizes, limiting subgroup-specific certainty. [1]

How Lincolnshire Knee helps you choose a pathway

In Lincolnshire clinics, the pathway is usually set out as a straightforward, stepwise decision—described here in plain language (rather than with the bracketed source tags that can appear in draft materials). The starting point is a consultant-led assessment that links symptoms to structure, typically combining examination with weight-bearing X‑rays and MRI where that extra detail changes management; local diagnostics are available in Sleaford (NG34) and Grantham (NG31), including an Open MRI option in Sleaford for people who struggle with closed scanners.

Recommendations then tend to follow a conservative-first sequence, particularly when imaging points to broader wear rather than a single, contained defect. That often means tightening up the fundamentals—physiotherapy-led strength and load management, day-to-day pain strategies, and (where appropriate) standard injection options—before escalating to cartilage restoration techniques that carry bigger rehabilitation and cost commitments.

A practical decision map used in clinic

The “best” next step is usually framed around the pattern of damage seen on imaging and the practicalities of treatment (time off work, rehab capacity, and budget), rather than the name of any one procedure:

• Diffuse or multi-compartment cartilage loss on MRI/X‑ray: the emphasis commonly stays on symptom control and joint-preservation measures, with arthroplasty discussions reserved for cases where the knee is no longer realistically “repairable” as a focal problem.
• A clearly focal defect with otherwise workable knee mechanics: options may include ultrasound-guided injection approaches for selected lesions, and—when surgery is the better match—one-stage procedures such as microfracture-based membrane augmentation techniques or two-stage cell-based repair such as MACI.
• A focal defect plus a major “driver” (for example, malalignment needing offloading): alignment procedures such as HTO/DFO may be part of the joint-preservation plan, because cartilage restoration tends to be less reliable if the compartment remains overloaded.

Because evidence strength varies across techniques, uncertainties are made explicit at the decision point. For example, established procedures such as MACI have longer-term outcome data in published series, while newer one-stage concepts are still developing and may be discussed as emerging options with referral to specialist centres considered only when appropriate. [1]

Lincolnshire Knee is part of the MSK Doctors group and accepts patients without GP referral; an assessment can be booked at lincolnshireknee.co.uk.

1. [1] Surface-based treatment options for cartilage lesions of the knee. (2026). https://doi.org/10.21037/aoj-2025-1-86 https://doi.org/10.21037/aoj-2025-1-86